Ruoyang Shao

Southern Medical University - Department of Hematology

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Dynamic MRD-Directed Post-Remission Treatment in Patients with Intermediate-Risk Acute Myeloid Leukemia in First Remission: Prospective Validation in a Multicentre Cohort

Number of pages: 32 Posted: 18 Sep 2024
Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Guangxi Medical University, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Southern Medical University - Shenzhen Hospital, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, First People’s Hospital of Chenzhou City, Maoming People’s Hospital, Peking University, Sun Yat-sen University (SYSU), South China University of Technology - Department of Hematology, Jinan University, Southern Medical University, Peking University, Zhongshan City People's Hospital, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Hunan Normal University, Guangxi Medical University, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology and Southern Medical University - Department of Hematology
Downloads 41 (926,710)

Abstract:

Loading...

Dynamic, measurable residual disease, post-remission treatment, intermediate-risk, acute myeloid leukemia